Picture of Laboratorio Reig Jofre SA logo

RJF — Laboratorio Reig Jofre SA News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareBalancedSmall CapNeutral

Spain's Reig Jofre new plant to produce J&J vaccine by end-Q2

MADRID, April 29 (Reuters) - Spanish pharmaceutical Reig
Jofre  RJFE.MC  said on Thursday that its new plant in Barcelona
will start producing the COVID-19 vaccine developed by U.S.
company Johnson & Johnson  JNJ.N  by the end of the second
quarter.
    The plant, which will allow the company to triple its
current capacity to manufacture sterile products this year, 
will reach full capacity later this year, Reig Jofre said in a
statement. 
    The company will be able to produce as many as 250 million
doses, it said.
    Along with the COVID-19 vaccine, it will manufacture other
products. 
    Reig Jofre agreed with Johnson & Johnson last year to
produce doses of the vaccine and initially said the plant would
start operating in the first quarter of 2021.        
 urn:newsml:reuters.com:*:nL1N2IV0I8

 (Reporting by Emma Pinedo; editing Inti Landauro and Jason
Neely)
 ((emma.pinedo@thomsonreuters.com; +918 35 68 34;))

Recent news on Laboratorio Reig Jofre SA

See all news